<div id="readability-page-1"><div id="news-body">(Yicai) April 13 -- Foreign medical device companies are adjusting their development strategies for the Chinese market, placing greater emphasis on localized research, development, and production to accelerate cutting-edge product launch and advance local manufacturing.Canon Medical Systems this year has achieved localized manufacturing of its products available in China, including computed tomography, digital subtraction angiography, X-ray, and ultrasound systems, Katsuya Takao, president and chief executive officer of Canon Medical Systems China, told Yicai at the 93rd China International Medical Equipment Fair. The firm is now pushing for local production of key components, he added.For example, Canon Medical's XR imaging system Ultimax-i, the key equipment of the integrated operating room solution for endoscopic retrograde cholangiopancreatography jointly developed by Canon Medical and Olympus, which has been adopted by hospitals in multiple Chinese regions, is being manufactured locally.Clinical demand for ERCP procedures in China is about 800,000 to one million cases a year, according to industry data. But due to technological complexity and uneven resource distribution, there is still a sizable gap between the actual number of ERCP procedures performed and clinical demand.Foreign medical device companies need to work closely with front-line Chinese clinicians and carry out localized new product development through local research and development teams to launch innovative products that better meet the needs of the Chinese market, Takao noted.China has long been a key strategic market for Canon Medical, and it will continue to promote localized development by deepening investment and presence in the country in terms of industrial chain collaboration, clinical cooperation, and service systems, Takao said.The core of Canon Medical's investment and layout in China is to effectively respond to the actual needs of Chinese medical institutions by integrating front-line clinical demand directly into the R&amp;D process, according to Takao.While promoting high-end products, Canon Medical will apply its core technological capabilities to the development of mid-tier models to better serve primary medical institutions in China, he added.At this year's CMEF, many other foreign companies highlighted their local manufacturing and R&amp;D capabilities in China.For example, almost 90 percent of the nearly 50 innovative products and integrated diagnosis and treatment solutions for major diseases displayed by Siemens Healthineers were developed by local innovation teams and were made in the country.The local production of Siemens Healthineers' two photon-counting CT models is scheduled to officially begin by the end of June, Hao Wang, president of the company's China branch and member of its Global Leadership Council, told Yicai.GE Healthcare brought more than 50 precision medicine innovations and several ecological partnerships to the CMEF this year, with 12 debut products and 11 new clinical application solutions.Over 60 percent of GE Healthcare's exhibits were developed by Chinese R&amp;D teams, and 95 percent were made in China. All innovative products that debuted at the fair integrate digital technologies, such as artificial intelligence.Editors: Tang Shihua, Futura Costaglione</div></div>

159883

159898

300760

GEHC

562600

Foreign medical device companies are enhancing their strategies in China, focusing on localized R&D and production. Canon Medical Systems has achieved local manufacturing of various medical products and aims to produce key components domestically. The company emphasizes collaboration with Chinese clinicians to meet local demands. Siemens Healthineers and GE Healthcare also showcased their local innovations at the China International Medical Equipment Fair, with a significant portion of their products developed and manufactured in China. This shift aims to address the growing clinical needs in the Chinese market.

Yicai

Siemens Healthineers AG

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

iShares US Medical Devices

Mindray

GE HealthCare Tech

SPDR S&P Health Equip

ChinaAMC CSI All Share Health Care Devices ETF

Global Medical Device Giants Upgrade China Strategies to Advance Local R&D, Production